Compounds > 2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one
Page last updated: 2024-09-02

2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one and argininic acid

2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one has been researched along with argininic acid in 1 studies

Compound Research Comparison

Studies
(2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one)		Trials
(2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one)		Recent Studies (post-2010)
(2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one)		Studies
(argininic acid)		Trials
(argininic acid)		Recent Studies (post-2010) (argininic acid)
56021524

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Deyn, PP; Macdonald, RL; Marescau, B1

Other Studies

1 other study(ies) available for 2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one and argininic acid

ArticleYear
Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell culture.
    Epilepsy research, 1991, Volume: 8, Issue:2

    Topics: Animals; Arginine; Cells, Cultured; Electrophysiology; Female; GABA Antagonists; gamma-Aminobutyric Acid; Glycine; Guanidines; Homoarginine; Mice; Neurons; Pregnancy; Pyrazoles; Spinal Cord

1991